We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This rapid evidence summary identified and summarised evidence relating to mpox asymptomatic and pre-symptomatic transmission.
Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.
Summary of the process and outcome evaluations of the re-engagement exercise designed to help patients with historical diagnoses re-engage with care.
Analysis of data for statutory notifications of infectious diseases (NOIDs) in England and Wales in 2024.
Technical briefing documents on the investigation into cases of mpox in England.
This rapid review identified and summarised evidence of the accuracy of new diagnostic tests for Clostridioides difficile (C. difficile).
Data tables and commentary for the Unlinked Anonymous Monitoring (UAM) Survey of infections and risk among people who inject drugs (PWID).
Monthly counts of Escherichia coli (E.coli) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of Clostridioides difficile (C. difficile) infections by NHS organisation and prior trust exposure (from April 2019) in patients aged 2 years and over.
Monthly counts of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of Klebsiella species (Klebsiella spp.) bacteraemia by organisation and location of onset (from April 2019).
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about vaccines for the 2025 to 2026 flu season.
Reported cases of Legionnaires’ disease in residents of England and Wales with onset of symptoms from 2017 to 2023.
Data on the real-world effectiveness and impact of the COVID-19 vaccines.
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programmes for 2025 and spring 2026.
Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.
Risk review and statement on the zoonotic risk avian influenza A(H5N1) clade 2.3.4.4b genotype B3.13 would present to people in contact with infected animals in the UK
This rapid review aims to identify and summarise evidence for the effectiveness of interventions.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).